Brokerages Anticipate Nu Skin Enterprises, Inc. (NYSE:NUS) Will Post Quarterly Sales of $579.41 Million

Brokerages expect Nu Skin Enterprises, Inc. (NYSE:NUSGet Rating) to report $579.41 million in sales for the current quarter, according to Zacks. Two analysts have made estimates for Nu Skin Enterprises’ earnings, with the lowest sales estimate coming in at $576.30 million and the highest estimate coming in at $582.53 million. Nu Skin Enterprises reported sales of $677.03 million during the same quarter last year, which would suggest a negative year over year growth rate of 14.4%. The business is scheduled to issue its next quarterly earnings report on Monday, January 1st.

On average, analysts expect that Nu Skin Enterprises will report full year sales of $2.72 billion for the current fiscal year. For the next financial year, analysts anticipate that the business will post sales of $2.80 billion, with estimates ranging from $2.78 billion to $2.82 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side analysts that follow Nu Skin Enterprises.

Nu Skin Enterprises (NYSE:NUSGet Rating) last issued its earnings results on Wednesday, February 16th. The company reported $1.11 earnings per share for the quarter, beating analysts’ consensus estimates of $0.95 by $0.16. The company had revenue of $673.44 million for the quarter, compared to the consensus estimate of $655.93 million. Nu Skin Enterprises had a return on equity of 23.39% and a net margin of 5.46%. The firm’s quarterly revenue was down 10.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.40 EPS.

Several equities research analysts recently commented on the company. Jefferies Financial Group boosted their price target on Nu Skin Enterprises from $61.00 to $75.00 in a research note on Thursday, February 17th. DA Davidson boosted their price target on Nu Skin Enterprises from $47.00 to $50.00 and gave the company a “neutral” rating in a research note on Thursday, February 17th. StockNews.com began coverage on Nu Skin Enterprises in a research note on Thursday, March 31st. They issued a “hold” rating for the company. Zacks Investment Research raised Nu Skin Enterprises from a “hold” rating to a “strong-buy” rating and set a $57.00 target price for the company in a research report on Tuesday, March 29th. Finally, TheStreet cut Nu Skin Enterprises from a “b” rating to a “c+” rating in a research report on Friday, February 18th. Four research analysts have rated the stock with a hold rating, one has given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus price target of $61.17.

In other news, CEO Ryan S. Napierski sold 25,000 shares of the stock in a transaction on Friday, February 25th. The stock was sold at an average price of $47.40, for a total transaction of $1,185,000.00. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Andrew D. Lipman sold 1,000 shares of the stock in a transaction on Tuesday, February 22nd. The stock was sold at an average price of $53.27, for a total value of $53,270.00. The disclosure for this sale can be found here. Insiders have sold 28,000 shares of company stock valued at $1,336,170 over the last quarter. Corporate insiders own 4.00% of the company’s stock.

Hedge funds have recently made changes to their positions in the company. Morgan Stanley boosted its holdings in Nu Skin Enterprises by 1.9% in the second quarter. Morgan Stanley now owns 360,382 shares of the company’s stock valued at $20,415,000 after acquiring an additional 6,652 shares during the last quarter. Exchange Traded Concepts LLC boosted its holdings in Nu Skin Enterprises by 27.7% during the third quarter. Exchange Traded Concepts LLC now owns 11,328 shares of the company’s stock worth $458,000 after buying an additional 2,456 shares during the last quarter. SummerHaven Investment Management LLC boosted its holdings in Nu Skin Enterprises by 61.8% during the third quarter. SummerHaven Investment Management LLC now owns 15,510 shares of the company’s stock worth $628,000 after buying an additional 5,926 shares during the last quarter. Virginia Retirement Systems ET AL boosted its holdings in Nu Skin Enterprises by 66.7% during the third quarter. Virginia Retirement Systems ET AL now owns 37,500 shares of the company’s stock worth $1,518,000 after buying an additional 15,000 shares during the last quarter. Finally, New York State Teachers Retirement System boosted its holdings in Nu Skin Enterprises by 5.1% during the third quarter. New York State Teachers Retirement System now owns 48,693 shares of the company’s stock worth $1,971,000 after buying an additional 2,345 shares during the last quarter. Institutional investors own 80.57% of the company’s stock.

Shares of NYSE NUS traded up $1.10 during trading hours on Friday, hitting $49.67. The stock had a trading volume of 470,807 shares, compared to its average volume of 437,559. The company has a market capitalization of $2.47 billion, a P/E ratio of 17.43 and a beta of 1.25. The firm’s 50-day moving average price is $48.63 and its two-hundred day moving average price is $46.91. Nu Skin Enterprises has a 52 week low of $39.40 and a 52 week high of $62.70. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.89 and a current ratio of 1.65.

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, March 9th. Shareholders of record on Monday, February 28th were paid a dividend of $0.385 per share. This is a positive change from Nu Skin Enterprises’s previous quarterly dividend of $0.38. This represents a $1.54 annualized dividend and a yield of 3.10%. The ex-dividend date of this dividend was Friday, February 25th. Nu Skin Enterprises’s dividend payout ratio is currently 54.04%.

Nu Skin Enterprises Company Profile (Get Rating)

Nu Skin Enterprises, Inc develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products.

Further Reading

Get a free copy of the Zacks research report on Nu Skin Enterprises (NUS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.